Tag: BCI
Neurolutions and Kandu partner to accelerate access to improved stroke rehabilitation
Neurolutions and Kandu Health recently announced a strategic partnership intended to raise the standard of care for post-stroke recovery. Through this partnership, Kandu’s expert...
NICO highlights study showing “first ever” successful deep-brain BCI implantation in...
A study demonstrating the successful deep-brain placement of a brain-computer interface (BCI) microchip into a living animal with no apparent neurological effects has been...
Butterfly Network and Forest Neurotech to partner on development of next-generation...
Digital health company Butterfly Network and deep tech research firm Forest Neurotech announced yesterday that they have entered into a five-year co-development agreement to...
Recent breakthroughs represent “baby steps” towards wider use of brain-computer interfaces
“The possibility to restore mobility to patients could have tremendous benefits,” says Mitchell Elkind, chief clinical science officer of the American Heart Association (AHA),...
Onward announces first-in-human implant of ARC-IM stimulator with wireless BCI device
Onward Medical has today announced the successful first-in-human implant of its ARC-IM stimulator intended to restore upper-extremity function after spinal cord injury (SCI). The...
Synchron completes enrolment in US COMMAND trial of endovascular brain-computer interface
Synchron has announced completion of patient enrolment in the USA-based COMMAND trial assessing the company’s endovascular brain-computer interface (BCI) technology.
“Giving patients the option to...
Precision Neuroscience begins first-in-human study of implantable BCI technology
Precision Neuroscience Corporation has announced that the first in-human procedures in a pilot clinical study of its neural implant system have been successfully completed....
Brain-computer interface plus SCS therapy enables thought-controlled walking after spinal cord...
Onward Medical has announced a recent publication in Nature showing that a wireless brain-computer interface (BCI) can use patients’ thoughts to modulate ARC therapy....
COMMAND trial set to begin enrolment at third US site
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is commencing enrolment at Gates Vascular Institute, a Kaleida Health...
Synchron announces publication of brain-computer interface clinical trial in JAMA Neurology
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe...
Onward awarded grant to continue developing brain-computer interface technology
Onward Medical has been awarded a second grant from the European Innovation Council (EIC) to support the continued development of its brain-computer interface (BCI)...
Positive animal-model results with ABILITY BCI are “important step” towards human...
The Wyss Center for Bio and Neuroengineering in Geneva, Switzerland has today revealed the latest preclinical neural data acquired with its fully implantable ABILITY...
Synchron to begin COMMAND trial enrolment at University of Pittsburgh
Synchron has announced that enrolment in the COMMAND trial has commenced at the University of Pittsburgh in Pittsburgh, USA.
The COMMAND trial is an early...
First US Stentrode implant heralds new field in neurointerventional surgery
Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...
Synchron announces first human brain-computer interface implant in the USA
Synchron has announced the first human brain-computer interface (BCI) implant in the USA. This procedure represents a significant technological milestone for scalable BCI devices...
Synchron enrols first patient in US COMMAND study of endovascular brain-computer...
Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...
Implantable brain-computer interface enables completely locked-in patient to communicate
Researchers at the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), in collaboration with the University of Tübingen (Tübingen, Germany), have enabled a person...
Synchron announces long-term safety results with Stentrode device for severe paralysis
Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...
Brain-computer interface technology opens up “whole new world” of therapies
“We are starting to help patients in ways that we did not think were possible,” Thomas Oxley (Mount Sinai Hospital, New York, USA) tells...
Synchron announces US$10 million NIH grant for US COMMAND trial
The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
First-in-human study demonstrates use of high-bandwidth wireless brain-computer interface
Results of the BrainGate clinical trial, published in the journal IEEE Transactions on Biomedical Engineering, detail the first-in-human use of a new wireless brain-computer interface (BCI) in patients with tetraplegia....
LIVE from SNIS: Endovascular brain-computer interface improves function in paralysed patient
According to late-breaking data presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting, a wireless endovascular brain–computer interface (BCI) “may improve capacity to perform activities in daily living...
